drugset / Trial / NCT04492683

Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children

NCT04492683 ↗

Phase 2 Unknown 230 enrolled DBV Technologies
Non-randomizedParallel-groupTriple-blindDiagnostic

Summary

Study to assess the diagnostic accuracy (sensitivity, specificity, positive and negative predictive value) of DBV1605 for the diagnosis of non-Immunoglobulin E (IgE) mediated cow's milk allergy (CMA) in children with symptoms suggestive of non-IgE mediated CMA.

Timeline

Start
2020-08-28
Primary completion
2024-03
Completion
2024-03

Drugs

EvaluationDrugModalityDoseRoute
Subject DBV1605 Diagnostic / imaging agent 180 ug Topical

Indications

No indication recorded.